Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-11-035999

Chief Executive Officer bought 10,000 shares at $4.40 ($43,962)

From the SEC's structured data for this filing

Trades in this filing

WEST MICHAEL D · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2011-06-22 Purchase : show line 1 in the form +10,000 $4.40 $43,962 79,600 D
Open-market purchases · 10,000 sh · avg $4.40 · $43,962
Loading xslF345X03/doc4.xml…